CoreCap Advisors’s Bio-Techne TECH Stock Holding History

CoreCap Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.7K	Buy	51 +15	+42%	+$1.08K	﹤0.01%	2333
2026 Q2	$2.54K	Sell	36 -2	-5%	-$108	﹤0.01%	2482
2026 Q1	$1.99K	Sell	38 -26	-41%	-$1.56K	﹤0.01%	2416
2025 Q4	$3.78K	Sell	64 -60	-48%	-$3.65K	﹤0.01%	2304
2025 Q3	$6.91K	Hold	124	–	–	﹤0.01%	2087
2025 Q2	$6.39K	Sell	124 -27	-18%	-$1.36K	﹤0.01%	2043
2025 Q1	$8.86K	Sell	151 -321	-68%	-$21.8K	﹤0.01%	1870
2024 Q4	$34K	Sell	472 -71	-13%	-$5.21K	﹤0.01%	1339
2024 Q3	$43.4K	Sell	543 -1	-0.2%	-$75	﹤0.01%	1252
2024 Q2	$39K	Buy	544 +1	+0.2%	+$74	﹤0.01%	723
2024 Q1	$38.2K	Buy	+543	New	+$38.9K	﹤0.01%	1213
2022 Q4	$124K	Buy	+1,500	New	+$119K	0.01%	656
2022 Q3	–	Sell	-1,688	Closed	-$146K	–	1918
2022 Q2	$146K	Sell	1,688 -384	-19%	-$36K	0.01%	586
2022 Q1	$224K	Sell	2,072 -2,792	-57%	-$288K	0.02%	482
2021 Q4	$629K	Buy	+4,864	New	+$596K	0.04%	317

Other funds holding TECH

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

CoreCap Advisors's TECH Position: Q3 2026 in Review

CoreCap Advisors increased its Bio-Techne (TECH) stake by 42% in Q3 2026, buying an estimated $1.08K and bringing the position to 51 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

CoreCap Advisors first reported a position in TECH in Q4 2021 and has held it in 15 quarters since. The position peaked at $629K in Q4 2021. 89 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

CoreCap Advisors held 51 shares of Bio-Techne worth $3.7K as of Q3 2026.
CoreCap Advisors bought 15 Bio-Techne shares in Q3 2026, an estimated $1.08K.
Bio-Techne made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2333 holding.
CoreCap Advisors first reported a position in Bio-Techne in Q4 2021 and has held it in 15 quarters since.
CoreCap Advisors's Bio-Techne position peaked at $629K in Q4 2021.
89 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.